Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Thrombocytopenia 2Lung Neoplasms 1Digestive System Diseases 1Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors 1Chemotherapy-induced Thrombocytopenia 1Chemotherapy Induced Thrombocytopenia 1Cancer Therapy-induced Thrombocytopenia (CTIT) 1Breast Neoplasms 1

Interventions

eltrombopag 6romiplostim 4avatrombopag 4Cytarabine 4Daunorubicin 3Cyclophosphamide 3oprelvekin 2hetrombopag 2Tretinoin 2Tranexamic Acid 2Radiotherapy 2Platelet Transfusion 2Filgrastim 2Etoposide 2Carboplatin 2sodium thiosulfate 1raltitrexed 1pegfilgrastim 1ofatumumab 1niraparib 1leridistim 1fludarabine 1etoposide phosphate 1angiotensin I (1-7) 1Vorinostat 1Vincristine 1Thioguanine 1Stem Cell Transplantation 1Sirolimus 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Thrombocytopenia × hetrombopag × Clear all
NCT05442632 2024-03-13

Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before Hepatectomy

Fudan University

Phase 2 Unknown
96 enrolled
Classical hematology

Digestive System Diseases, Thrombocytopenia

NCT06036966 2023-09-14

The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Maintenance in Advanced Ovarian Cancer Patients

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Unknown
34 enrolled
Classical hematology

Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡